A crosstalk between bone and gonads

Annals of the New York Academy of Sciences

Volumn 1260, Issue 1, 2012, Pages 1-7

  Oury, Franck ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Bone; Gonads; Gprc6a; Osteocalcin; Sex steroids

Indexed keywords

ANDROGEN; ESTROGEN; GLUCOSE; OSTEOCALCIN; TESTOSTERONE;

BONE; BONE GROWTH; BONE MASS; ENERGY EXPENDITURE; ENERGY METABOLISM; GONAD; HUMAN; IN VIVO STUDY; LEYDIG CELL; MOLECULAR INTERACTION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; REPRODUCTION; REVIEW; TESTOSTERONE SYNTHESIS;

EID: 84864072373     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06360.x     Document Type: Review

References (65)

1. Khosla, S. et al. 2001. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J. Clin. Endocrinol. Metab. 86: 3555-3561.
2. Riggs, B.L. et al. 1998. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J. Bone Miner. Res. 13: 168-174.
3. Nakamura, T. et al. 2007. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130: 811-823.
4. Riggs, B.L. et al. 2002. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23: 279-302.
5. Khosla, S. & B.L. Riggs. 2005. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol. Metab. Clin. North Am. 34: 1015-1030, xi.
6. Vanderschueren, D. et al. 2004. Androgens and bone. Endocr. Rev. 25: 389-425.
7. Lee, N.K. et al. 2007. Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456-469.
8. Oury, F. et al. 2010. Endocrine regulation of male fertility by the skeleton. Cell 144: 796-809.
9. Harada, S. & G.A. Rodan. 2003. Control of osteoblast function and regulation of bone mass. Nature 423: 349-355.
10. Rodan, G.A. & T.J. Martin. 2000. Therapeutic approaches to bone diseases. Science 289: 1508-1514.
11. Teitelbaum, S.L. 2000. Osteoclasts, integrins, and osteoporosis. J. Bone Miner. Metab. 18: 344-349.
12. Karsenty, G. 2006. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab. 4: 341-348.
13. Seeman, E. 2001. Clinical review 137: sexual dimorphism in skeletal size, density, and strength. J. Clin. Endocrinol. Metab. 86: 4576-4584.
14. Kirmani, S. et al. 2009. Bone structure at the distal radius during adolescent growth. J. Bone Miner. Res. 24: 1033-1042.
15. Venken, K. et al. 2006. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J. Bone Miner. Res. 21: 576-585.
16. Wakley, G.K. et al. 1991. Androgen treatment prevents loss of cancellous bone in the orchidectomized rat. J. Bone Miner. Res. 6: 325-330.
17. Turner, R.T. et al. 1990. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J. Orthop. Res. 8: 612-617.
18. Seeman, E. 2002. Pathogenesis of bone fragility in women and men. Lancet 359: 1841-1850.
19. Katznelson, L. et al. 1996. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J. Clin. Endocrinol. Metab. 81: 4358-4365.
20. Bertelloni, S. et al. 1995. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J. Bone Miner. Res. 10: 1488-1495.
21. Finkelstein, J.S. et al. 1996. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J. Clin. Endocrinol. Metab. 81: 1152-1155.
22. Buchanan, J.R. et al. 1988. Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise. J. Bone Miner. Res. 3: 673-680.
23. Zborowski, J.V. et al. 2001. Clinical Review 116: bone mineral density, androgens, and the polycystic ovary. The complex and controversial issue of androgenic influence in female bone. J. Clin. Endocrinol. Metab. 85: 3496-3506.
24. Wei, S. et al. 2010. Menstrual irregularity and bone mass in premenopausal women: cross-sectional associations with testosterone and SHBG. BMC Musculoskelet Disord. 11: 288-296.
25. Callewaert, F. et al. 2009. Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. J. Endocrinol. 207: 127-134.
26. Lupu, F. et al. 2001. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev. Biol. 229: 141-162.
27. Callewaert, F. et al. 2010. Sex steroids and the male skeleton: a tale of two hormones. Trends Endocrinol. Metab. 21: 89-95.
28. Stepan, J.J. et al. 1989. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J. Clin. Endocrinol. Metab. 69: 523-527.
29. Kaufman, J.M. & A. Vermeulen. 2005. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 26: 833-876.
30. Araujo, A.B. et al. 2008. Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. J. Clin. Endocrinol. Metab. 93: 2135-2141.
31. Mellstrom, D. et al. 2006. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J. Bone Miner. Res. 21: 529-535.
32. van den Beld, A.W. et al. 2000. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J. Clin. Endocrinol. Metab. 85: 3276-3282.
33. Bouillon, R. et al. 2004. Estrogens are essential for male pubertal periosteal bone expansion. J. Clin. Endocrinol. Metab. 89: 6025-6029.
34. Rochira, V. et al. 2007. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone. Bone 40: 1662-1668.
35. Imai, Y. et al. 2009. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. Ann. N.Y. Acad. Sci. 1173(Suppl 1): E31-E39.
36. Hughes, D.E. et al. 1996. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat. Med. 2: 1132-1136.
37. Majeska, R.J. et al. 1994. Direct modulation of osteoblastic activity with estrogen. J. Bone Joint Surg. Am. 76: 713-721.
38. Qu, Q. et al. 1998. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 22: 201-209.
39. Xing, L. & B.F. Boyce. 2005. Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem. Biophys. Res. Commun. 328: 709-720.
40. Jimi, E. et al. 1996. Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells. J. Biol. Chem. 271: 4605-4608.
41. Pacifici, R. 1996. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res. 11: 1043-1051.
42. Manolagas, S.C. et al. 2002. Sex steroids and bone. Recent Prog. Horm. Res. 57: 385-409.
43. Tau, K.R. et al. 1998. Estrogen regulation of a transforming growth factor-beta inducible early gene that inhibits deoxyribonucleic acid synthesis in human osteoblasts. Endocrinology 139: 1346-1353.
44. Gill, R.K. et al. 1998. Orchiectomy markedly reduces the concentration of the three isoforms of transforming growth factor beta in rat bone, and reduction is prevented by testosterone. Endocrinology 139: 546-550.
45. Bodine, P.V. et al. 1995. Regulation of c-fos expression and TGF-beta production by gonadal and adrenal androgens in normal human osteoblastic cells. J. Steroid Biochem. Mol. Biol. 52: 149-158.
46. Michael, H. et al. 2005. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J. Bone Miner. Res. 20: 2224-2232.
47. Krum, S.A. et al. (2008) Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 27: 535-545.
48. Jilka, R.L. et al. 1992. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257: 88-91.
49. Kasperk, C.H. et al. 1989. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124: 1576-1578.
50. Kousteni, S. et al. 2002. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298: 843-846.
51. Kousteni, S. et al. 2001. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104: 719-730.
52. Noble, B. et al. 1999. Androgen receptors in bone-forming tissue. Horm. Res. 51: 31-36.
53. Bord, S. et al. 2001. Estrogen receptors alpha and beta are differentially expressed in developing human bone. J. Clin. Endocrinol. Metab. 86: 2309-2314.
54. Couse, J.F. & K.S. Korach. 1999. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20: 358-417.
55. Vidal, O. et al. 2000. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc. Natl. Acad. Sci. USA 97: 5474-5479.
56. Oz, O.K. et al. 2000. Bone has a sexually dimorphic response to aromatase deficiency. J. Bone Miner. Res. 15: 507-514.
57. Lindberg, M.K. et al. 2001 Estrogen receptor specificity in the regulation of the skeleton in female mice. J. Endocrinol. 171: 229-236.
58. Ferron, M. et al. 2010. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142: 296-308.
59. Fulzele, K. et al. 2010. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142: 309-319.
60. Yoshikawa, Y. et al. 2011. Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. J. Bone Miner. Res. 26: 2012-2025.
61. Pi, M. et al. 2008. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One 3: e3858.
62. Pi, M. et al. 2011. GPRC6A mediates responses to osteocalcin in beta-cells in vitro and pancreas in vivo. J. Bone Miner. Res. 26: 1680-1683.
63. Kirmani, S. et al. 2011. Relationship of testosterone and osteocalcin levels during growth. J. Bone Miner. Res. 26: 2212-2216.
64. Takata, R. et al. 2010. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat. Genet. 42: 751-754.
65. Pi, M. & L.D. Quarles. GPRC6A regulates prostate cancer progression. Prostate 21442: 1-11.